-Johns Hopkins University - Inhibitor Drug Entinostat 'Primes' the Body to Better Respond to Anti-Cancer Treatment with Immunotherapy

Press/Media

Period17 Aug 2021

Media coverage

1

Media coverage

  • Title-Johns Hopkins University - Inhibitor Drug Entinostat 'Primes' the Body to Better Respond to Anti-Cancer Treatment with Immunotherapy
    Media name/outletENP Newswire
    Country/TerritoryUnited Kingdom
    Date17/08/21
    PersonsRoisin Connolly
View all 1
View less